Cellebrite Completes Acquisition of Paladin Portfolio Company Corellium
Paladin made its first investment in Corellium in its 2021 Series A round Washington, D.C. – Cellebrite (NASDAQ: CLBT) has completed its acquisition of Paladin Capital Group portfolio company Corellium, resulting in an excellent return on capital to Paladin’s Limited Partners. The deal has an enterprise value of up to $200 million, a portion of which is […]